Indatraline

This classification denotes an antidepressant agent with the molecular formula C16H15Cl2N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4U40Y96J1Z, chemically known as 3-(3,4-dichlorophenyl)-n-methyl-1-indanamine hcl but generally known as indatraline, which bears US NIH Compound Identifier 126280. European Medicines Agency schedules Indatraline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08170MIG. The term INDATRALINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). INDATRALINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule indatraline under HS 29214980 and SITC 51454. As of Q4 2014, INDATRALINE remains the US FDA Preferred Term for this commodity. Indatraline bears US NLM identifiers UMLS ID C0065216 and NCI Concept Code C83797. SMILES: Clc1cc(C2CC(NC)c3c2cccc3)ccc1Cl.